Vaccine Choice Canada Human Papillomavirus - Disease & Vaccine Information

Human Papillomavirus

Human Papillomavirus (HPV) is a disease that is spread through genital contact. There are more than 200 known types of human papilloma viruses. In more than 90% of cases the immune system naturally clears the infection without symptoms or complications. The concern with contracting HPV is the risk that chronic infection may lead to cervical cancer. In Western nations, cervical cancer is rare due to early detection via Pap screening programs. At highest risk of HPV infection, complications are less than ten percent of women and men who do not naturally clear HPV infections and therefore, become chronically infected. High risk factors for developing HPV-related cancers include: smoking, multiple sexual partners, long-term oral contraceptive use, multiple births, weakened immune system, co-infection with Chlamydia or HIV, poor nutrition, heavy drinking and smoking, and chronic inflammation.

The Vaccine

The HPV vaccines are promoted as a way to prevent cervical cancer. As of August 2018, there are no studies that confirm the HPV vaccine has reduced the incidence of HPV associated cancers.
HPV have so many strains and mutate so rapidly that vaccination does little to reduce the prevalence of the disease and actually causes an increase in the strains not covered by the vaccine.
HPV vaccines do not reduce HPV types not covered by the vaccine. 21% of HPV associated cancers involve HPV types not included in the Gardasil 9 vaccine.
HPV vaccines are deemed effective based on their ability to produce antibodies rather than their proven ability to reduce cervical cancer.
Gardasil vaccine contains 9 different HPV viruses and an aluminum compound. Aluminum is a known neurotoxin.

Considerations for the Vaccine Decision

Studies have shown that teenage girls have NO risk of dying from cervical cancer.
HPV vaccines cannot treat existing HPV infections.
HPV vaccine does not replace the need for routine cervical cancer screenings.
Cervical cancer has been reported in women who have received HPV vaccine.
The HPV vaccine has one of the highest rates of adverse events reported following vaccination.
There is no substantive evidence the HPV vaccine reduces the risk of cervical cancer.
There is substantive evidence that the HPV vaccine causes or contributes to adverse events that can negatively impact long term health, including infertility.
The US Vaccine Court has ruled that the HPV vaccine causes autoimmune narcolepsy.
As of May 31, 2023, the Vaccine Adverse Events Reporting System contains more than 73,955 reports of HPV vaccine reactions including 627 related deaths, 7,457 hospitalizations, and 3,555 disabling conditions. Over 55% of the reported serious adverse events occurred in children and teens under 17 years of age. [26]
A US HHS study acknowledged that less than 1% of vaccine adverse events are reported. [27]
HPV vaccines have not been proven safe by comparison to a true placebo.

For more information: https://www.nvic.org/disease-vaccine/hpv

References

[26] https://www.nvic.org/disease-vaccine/hpv/quick-facts

[27] Vaccine Adverse Events Reporting System – https://digital.ahrq.gov/sites/default/files/docs/publication/r18hs017045-lazarus-final-report-2011.pdf

Vaccine Product Monographs

Product: Gardasil 9 (Merck)

Product Monograph: https://www.merck.ca/en/wp-content/uploads/sites/20/2021/04/GARDASIL_9-PM_E.pdf (49 pages)

Patient Information sheet: https://www.merck.ca/en/wp-content/uploads/sites/20/2021/04/GARDASIL_9-CI_E.pdf

Manufacturer website: https://www.merck.ca/en/vaccines-2/